-
Date Time 11:00 - 12:00
Location Webinar Timezone America/New York
Managing safety cases is becoming more complex due to ever-increasing volume and variety of data. These common but evolving challenges point to the development of common frameworks leading to industry-wide solutions that can be adapted or tailored to specific needs.
This webcast, co-hosted by Oracle and ICON, will discuss why, from a CRO perspective, the cloud and AI are important milestones on the journey to the new world of safety.
On-Demand Webinar Archive
To access the archived recording of this webinar, visit our webinar channel and complete a one time only form. This will give you access to our entire library of archived webinars.
![Andrew Garrett Andrew Garrett](https://icon.widen.net/content/00f676b6-10d9-42fb-95c8-20bf0a45a2a3/web/Garrett_Andrew.png?crop=yes&w=240&h=240&itok=qChxeWg9)
Andrew Garrett
Andrew Garrett is responsible for strategic direction and operational execution of ICON’s Global Scientific Operations. He was Chair and founder of the Royal Statistical Society’s Data Science Section having previously been VP/Honorary Secretary of the RSS, and Chair of its Long Term Strategy Group. He was previously a Board member of the UK’s Administrative Data Research Network and is currently a member of UKSA’s Research Accreditation Panel that oversees the approval of research projects in accordance with the Digital Economy Act 2018. Andy has a BSc in Economics, an MSc in Medical Statistics and a PhD in Applied Statistics. He has worked extensively in the area of rare diseases and has a portfolio of published papers on the topics of non-inferiority trials, subgroup analysis, data transparency and modelling and simulation.
![Quintin Van Wyk Quintin Van Wyk](https://icon.widen.net/content/7e3deda0-6ddf-4561-8665-6231b02cdd4a/web/VanWyk_Quintin.png?crop=yes&w=240&h=240&itok=cjsvuD4H)
Quintin Van Wyk
Quintin has 17 years of experience at ICON and in Pharmacovigilance. He joined ICON as a Clinical Research Physician in 2003 and was involved in medical monitoring and drug safety since that time and also provided oversight of Global Regulatory Affairs, Medical Writing and Publishing. Quintin has worked on a variety of indications across all phases of clinical trials. In his current role as Vice President, Quintin oversees Pharmacovigilance and Safety Reporting, including Safety Regulatory Intelligence. Quintin is based in ICON’s Eastleigh office in the UK.